263 related articles for article (PubMed ID: 781380)
21. Activation of the alternative complement pathway by unidentified substances in human glomerulonephritis.
Schena FP; Pertosa G; Vox E; Bonomo L
Nephron; 1981; 27(1):9-14. PubMed ID: 6908651
[TBL] [Abstract][Full Text] [Related]
22. Inherited deficiency of the second component of complement (C2) with membranoproliferative glomerulonephritis.
Kim Y; Friend PS; Dresner IG; Yunis EJ; Michael AF
Am J Med; 1977 May; 62(5):765-71. PubMed ID: 860727
[TBL] [Abstract][Full Text] [Related]
23. Renal transplantation for patients with type I and type II membranoproliferative glomerulonephritis: serial complement and nephritic factor measurements and the problem of recurrence of disease.
Curtis JJ; Wyatt RJ; Bhathena D; Lucas BA; Holland NH; Luke RG
Am J Med; 1979 Feb; 66(2):216-25. PubMed ID: 371395
[TBL] [Abstract][Full Text] [Related]
24. Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis.
Whaley K; Ward D; Ruddy S
Clin Exp Immunol; 1979 Jan; 35(1):101-6. PubMed ID: 85507
[TBL] [Abstract][Full Text] [Related]
25. Developmental aspects of complement components in the newborn. The presence of complement components and C3 proactivator (properdin factor B) in human colostrum.
Ballow M; Fang F; Good RA; Day NK
Clin Exp Immunol; 1974 Oct; 18(2):257-66. PubMed ID: 4478765
[TBL] [Abstract][Full Text] [Related]
26. Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease.
Velosa J; Miller K; Michael AF
Am J Pathol; 1976 Jul; 84(1):149-62. PubMed ID: 779494
[TBL] [Abstract][Full Text] [Related]
27. Complement and mesangiocapillary glomerulonephritis: the role of complement deficiency in glomerulonephritis.
Peters DK; Williams DG
Adv Nephrol Necker Hosp; 1974; 4():67-78. PubMed ID: 4220000
[No Abstract] [Full Text] [Related]
28. Mesangial proliferative glomerulonephritis with irregular intramembranous deposits. Another variant of hypocoplementemic nephritis.
Davis AE; Schneeberger EE; McCluskey RT; Grupe WE
Am J Med; 1977 Sep; 63(3):481-7. PubMed ID: 331950
[TBL] [Abstract][Full Text] [Related]
29. Glomerular paramesangial deposits: association with hypocomplementemia in membranoproliferative glomerulonephritis types I and III.
West CD; McAdams AJ
Am J Kidney Dis; 1998 Mar; 31(3):427-34. PubMed ID: 9506679
[TBL] [Abstract][Full Text] [Related]
30. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
Geiger H; Good RA; Day NK
Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
[TBL] [Abstract][Full Text] [Related]
31. Differences between membranoproliferative glomerulonephritis types I and III in clinical presentation, glomerular morphology, and complement perturbation.
Jackson EC; McAdams AJ; Strife CF; Forristal J; Welch TR; West CD
Am J Kidney Dis; 1987 Feb; 9(2):115-20. PubMed ID: 3826060
[TBL] [Abstract][Full Text] [Related]
32. Human glomerulonephritis and the C3 nephritic factor (C3NeF).
Berthoux FC; Carpenter CB; Freyria AM; Traeger J; Merrill JP
Clin Nephrol; 1976 Mar; 5(3):93-100. PubMed ID: 57022
[No Abstract] [Full Text] [Related]
33. Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy.
Corvillo F; Bravo García-Morato M; Nozal P; Garrido S; Tortajada A; Rodríguez de Córdoba S; López-Trascasa M
Clin Exp Immunol; 2016 Apr; 184(1):118-25. PubMed ID: 26660535
[TBL] [Abstract][Full Text] [Related]
34. Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN).
Ohi H; Yasugi T
Clin Exp Immunol; 1994 Feb; 95(2):316-21. PubMed ID: 8306508
[TBL] [Abstract][Full Text] [Related]
35. Serum terminal complement component levels in hypocomplementemic glomerulonephritides.
Clardy CW; Forristal J; Strife CF; West CD
Clin Immunol Immunopathol; 1989 Mar; 50(3):307-20. PubMed ID: 2917423
[TBL] [Abstract][Full Text] [Related]
36. Evidence for activation of the alternate pathway in glomerulonephritis.
Michael AF; McLean RH
Adv Nephrol Necker Hosp; 1974; 4():49-66. PubMed ID: 4219999
[No Abstract] [Full Text] [Related]
37. Immunoglobulin and complement deposits in lupus glomerulonephritis.
Méry JP; Morel-Maroger L; Boelaert J
Proc Eur Dial Transplant Assoc; 1975; 11():506-11. PubMed ID: 1197274
[No Abstract] [Full Text] [Related]
38. Glomerular complement components in human glomerulonephritis.
Verroust PJ; Wilson CB; Cooper NR; Edgington TS; Dixon FJ
J Clin Invest; 1974 Jan; 53(1):77-84. PubMed ID: 4586873
[TBL] [Abstract][Full Text] [Related]
39. Membranoproliferative glomerulonephritis type III: association of glomerular deposits with circulating nephritic factor-stabilized convertase.
West CD; McAdams AJ
Am J Kidney Dis; 1998 Jul; 32(1):56-63. PubMed ID: 9669425
[TBL] [Abstract][Full Text] [Related]
40. Complement activation in acute glomerulonephritis in children.
Levy M; Sich M; Pirotzky E; Habib R
Ric Clin Lab; 1980; 10(1):87-91. PubMed ID: 7008160
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
